ATE443076T1 - Von protease typ ii spaltbares peptid - Google Patents
Von protease typ ii spaltbares peptidInfo
- Publication number
- ATE443076T1 ATE443076T1 AT99930951T AT99930951T ATE443076T1 AT E443076 T1 ATE443076 T1 AT E443076T1 AT 99930951 T AT99930951 T AT 99930951T AT 99930951 T AT99930951 T AT 99930951T AT E443076 T1 ATE443076 T1 AT E443076T1
- Authority
- AT
- Austria
- Prior art keywords
- tropoelastin
- amino acid
- derivatives
- claveable
- peptide
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title abstract 4
- 239000004365 Protease Substances 0.000 title abstract 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 108010014258 Elastin Proteins 0.000 abstract 4
- 102100033167 Elastin Human genes 0.000 abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 239000000816 peptidomimetic Substances 0.000 abstract 3
- 101000851054 Homo sapiens Elastin Proteins 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- External Artificial Organs (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP4723A AUPP472398A0 (en) | 1998-07-17 | 1998-07-17 | Protease susceptibility II |
| PCT/AU1999/000580 WO2000004043A1 (en) | 1998-07-17 | 1999-07-19 | Protease susceptibility ii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE443076T1 true ATE443076T1 (de) | 2009-10-15 |
Family
ID=3808961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99930951T ATE443076T1 (de) | 1998-07-17 | 1999-07-19 | Von protease typ ii spaltbares peptid |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7229788B1 (de) |
| EP (1) | EP1100815B1 (de) |
| JP (1) | JP4342731B2 (de) |
| AT (1) | ATE443076T1 (de) |
| AU (1) | AUPP472398A0 (de) |
| CA (1) | CA2335098C (de) |
| DE (1) | DE69941433D1 (de) |
| WO (1) | WO2000004043A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2393724B (en) * | 2002-10-01 | 2006-04-12 | Johnson & Johnson Medical Ltd | Controlled release therapeutic wound dressings |
| CN102348464B (zh) | 2009-03-10 | 2016-05-25 | 悉尼大学 | 可注射生物材料 |
| GB201102189D0 (en) * | 2011-02-08 | 2011-03-23 | King S College London | Materials and methods relating to cardiovascular imaging |
| KR20190040373A (ko) | 2011-09-30 | 2019-04-17 | 엘라스타겐 피티와이 리미티드 | 탄력섬유의 생체 내 합성 |
| FR2986233B1 (fr) * | 2012-02-01 | 2014-02-28 | Regentis Internat | Peptide bifonctionnel |
| US9688741B2 (en) | 2012-10-23 | 2017-06-27 | Elastagen Pty Ltd | Elastic hydrogel |
| DK2928512T3 (en) | 2012-12-10 | 2018-12-10 | Elastagen Pty Ltd | SCALABLE MANUFACTURE OF THREE-DIMENSIONAL ELASTIC CONSTRUCTIONS |
| KR102488446B1 (ko) | 2013-08-13 | 2023-01-13 | 앨러간 파마슈티컬스 인터내셔널 리미티드 | 손상 조직의 재생 |
| MX2016009817A (es) * | 2014-01-27 | 2017-02-28 | Auspex Pharmaceuticals Inc | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. |
| US20190275087A1 (en) | 2018-03-01 | 2019-09-12 | Allergan Pharmaceuticals International Limited | Expansion and differentiation of stem cells |
| SG11202111349QA (en) * | 2019-04-12 | 2021-11-29 | Geltor Inc | Recombinant elastin and production thereof |
| EP3962517A1 (de) | 2019-05-03 | 2022-03-09 | Allergan Pharmaceuticals International Limited | Vorbeugung und/oder behandlung von narben |
| ES3024564T3 (en) | 2019-08-23 | 2025-06-04 | Allergan Pharmaceuticals Int Ltd | Tropoelastin for use in treatment of acne scarring |
| WO2021124225A1 (en) | 2019-12-18 | 2021-06-24 | Allergan Pharmaceuticals International, Ltd | Hybrid polymeric materials and uses thereof |
| BR112022015583A2 (pt) | 2020-02-06 | 2022-10-11 | Allergan Pharmaceuticals Int Ltd | Andaimes de engenharia de tecidos |
| JP2023525155A (ja) | 2020-05-14 | 2023-06-14 | アラーガン ファーマシューティカルズ インターナショナル リミテッド | ヒアルロン酸に架橋したトロポエラスチンを含む組成物及びその使用方法 |
| CN117106029A (zh) * | 2020-06-08 | 2023-11-24 | 深圳市图微安创科技开发有限公司 | 靶向于纤连蛋白衍生肽的抑制剂多肽化合物及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ258820A (en) | 1992-12-22 | 1997-07-27 | Univ Sydney | Recombinant tropoelastins and their preparation |
| US5726040A (en) | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
| US7001328B1 (en) * | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
| US6451326B2 (en) | 1996-05-02 | 2002-09-17 | Burt D. Ensley | Cosmetic compositions |
| AU728480B2 (en) | 1996-08-07 | 2001-01-11 | Hospital For Sick Children, The | Self-aligning peptides derived from elastin and other fibrous proteins |
| AU741851B2 (en) | 1997-07-18 | 2001-12-13 | Elastagen Pty Ltd | Tropoelastin derivatives |
| AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
-
1998
- 1998-07-17 AU AUPP4723A patent/AUPP472398A0/en not_active Abandoned
-
1999
- 1999-07-19 CA CA2335098A patent/CA2335098C/en not_active Expired - Lifetime
- 1999-07-19 WO PCT/AU1999/000580 patent/WO2000004043A1/en not_active Ceased
- 1999-07-19 DE DE69941433T patent/DE69941433D1/de not_active Expired - Lifetime
- 1999-07-19 AT AT99930951T patent/ATE443076T1/de not_active IP Right Cessation
- 1999-07-19 US US09/743,818 patent/US7229788B1/en not_active Expired - Lifetime
- 1999-07-19 EP EP99930951A patent/EP1100815B1/de not_active Expired - Lifetime
- 1999-07-19 JP JP2000560149A patent/JP4342731B2/ja not_active Expired - Lifetime
-
2007
- 2007-05-08 US US11/801,120 patent/US20080058261A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7229788B1 (en) | 2007-06-12 |
| JP2002520421A (ja) | 2002-07-09 |
| US20080058261A1 (en) | 2008-03-06 |
| WO2000004043A1 (en) | 2000-01-27 |
| CA2335098A1 (en) | 2000-01-27 |
| AUPP472398A0 (en) | 1998-08-13 |
| EP1100815A4 (de) | 2005-05-25 |
| EP1100815B1 (de) | 2009-09-16 |
| EP1100815A1 (de) | 2001-05-23 |
| DE69941433D1 (de) | 2009-10-29 |
| JP4342731B2 (ja) | 2009-10-14 |
| CA2335098C (en) | 2012-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE443076T1 (de) | Von protease typ ii spaltbares peptid | |
| YU8997A (sh) | Prečišćen protein koji ima serinsku proteaznu inhibitorsku aktivnost i farmaceutski preparat koji ga sadrži | |
| MXPA03010079A (es) | Formulaciones de oxicodona de administracion una vez al dia. | |
| WO2002026947A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2001072977A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002034922A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002042437A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002046407A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002016566A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002050286A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2002077166A3 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
| WO2001081412A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof | |
| WO2002046406A3 (en) | Human transporter proteins, nucleic acid molecules encoding them,and uses thereof | |
| WO2001081413A3 (en) | Isolated human transporter proteins, nucleic acids and uses thereof | |
| WO2002074974A3 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
| WO2002050283A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof | |
| WO2002018554A3 (en) | Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof | |
| WO2002033086A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002020757A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002046217A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| WO2002024748A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof | |
| DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide | |
| WO2002057310A3 (en) | Human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2002024910A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof | |
| WO2002066642A3 (en) | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |